Search Results 801-810 of 17032 for pharmacogenetics
Mayo Clinic Researchers Identify Potential Immunotherapy Drug Combination for Targeting Advanced and Metastatic Cancers. Julie Janovsky-Mason. July 12, 2016.
Mayo Clinic is a nonprofit organization and proceeds from Web advertising help support our mission. Mayo Clinic does not endorse any of the third party products ...
About this study. The pupose of this study is to determine whether the scales marketed to the consumer are as accurate as the DEXA and InBody 970® for ...
Drugs used in chemotherapy, such as bleomycin, carboplatin, etoposide, and cisplatin, work in different ways to stop the growth of tumor cells, either by ...
About this study. The purpose of this study is to obtain time-series pressure (mmHg) data using a non-invasive pneumatic capture device designed by the Mayo ...
Latest stories · Discovery's Edge: A Foundation of Cancer Research featured image · Sharing Mayo Clinic: Genetic Testing Uncovers the Reason for Years of ...
The purpose of this study is to compare the effects (good and bad) on patients with prostate cancer by comparing the standard dose of radiation therapy (44 ...
Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.
Pharmacogenetic Testing in Children With Persistent Gastroesophageal Reflux Disease Rochester, MN. This study will use a 22 gene pharmacogenomics panel on 30 ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.